Head-to-Head

Abbott Laboratories vs. Royalty Pharma plc Class A Ordinary Shares

ABT

Abbott Laboratories

$111.25 -0.02%

VS RPRX

Royalty Pharma plc Class A Ordinary Shares

$58.60 +0.07%

Royalty Pharma plc Class A Ordinary Shares (RPRX) comes out ahead, leading on 6 of 11 compared factors.

Size & Scale

ABTRPRX
Market Cap $191.92 billion $26.37 billion
Revenue (TTM) $46.59 billion $2.54 billion
Net Income (TTM) $5.42 billion $1.35 billion

ABT leads on 3 of 3 size & scale factors.

Valuation

ABTRPRX
P/E Ratio 36.00 31.17
Price / Book 3.71 2.69
Price / Sales 4.12 10.40

RPRX leads on 2 of 3 valuation factors.

Profitability

ABTRPRX
Net Margin 11.65% 53.23%
Return on Equity 10.48% 13.79%

RPRX leads on 2 of 2 profitability factors.

Dividend

ABTRPRX
Dividend Yield 2.27% 1.60%
Payout Ratio 81.55 50.00

ABT and RPRX split the dividend factors evenly.

Risk & Sentiment

ABTRPRX
Short Interest 0.57% 0.34%

RPRX leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, RPRX overview, RPRX financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.